Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
β Scribed by Takeshita, H; Ichikawa, D; Komatsu, S; Tsujiura, M; Kosuga, T; Deguchi, K; Konishi, H; Morimura, R; Shiozaki, A; Fujiwara, H
- Book ID
- 110000451
- Publisher
- Nature Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 347 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Nuclear deoxyribonucleic acid (DNA) content is a prognostic factor in several tumors, and decisions regarding treatment have been made using this parameter. Nevertheless, there is no agreement in head and neck cancer. The purpose of the present study was to ascertain whether tumor DNA co
This study was conducted to evaluate the clinical usefulness of serum hCGβ€ in the diagnosis and prognosis of patients (n β«Ψβ¬ 59) with cancers of the oral cavity and oropharynx. As a reference marker we used squamous-cell carcinoma antigen (SCCAg). A blood sample was obtained from all patients before